1. The past time-series ILI occurrences over the 5 weeks demonstrate a consistent upward trend, with values of ['10080', '10778', '12532', '13484', '14343']. This steady increase from 10080 in Week 13, 2022, to 14343 in Week 17, 2022, represents a consistent escalation in ILI activity over the observed period. The highest value, 14343, recorded in Week 17, 2022, suggests ongoing intensification of ILI occurrences into the subsequent period.

2. A strong positive correlation between past and future ILI occurrences is observed. The progressive increase in ILI activity during Week 13, 2022, through Week 17, 2022, provides a clear trajectory that aligns with the substantial rise to 23985 after 5 weeks (Week 22, 2022). This observed growth in preceding weeks serves as a precursor to the sharp surge in future ILI numbers.

3. Several factors from the summarized reports correlate with the increased future ILI occurrences:  
   - The proportion of outpatient visits for respiratory illness increased from 1.9% (Week 13, 2022) to 2.2% (Week 17, 2022), indicating a rising trend in respiratory disease burden, possibly fueling the future increase.  
   - Cumulative hospitalization rates for influenza rose from 8.0 per 100,000 (Week 13, 2022) to 12.2 per 100,000 (Week 17, 2022), representing intensifying severe influenza activity, which likely contributed to increased ILI reporting.  
   - The co-circulation of multiple respiratory viruses, including SARS-CoV-2, alongside challenges in attribution and virologic surveillance, compound the burden of respiratory illnesses and likely influenced the significant future surge.  
   - PIC (Pneumonia, Influenza, or COVID-19)-related deaths consistently exceeded epidemic thresholds (from 7.5% in Week 13 to 7.2% in Week 17, 2022), reflecting sustained high respiratory illness mortality and signaling elevated illness severity.

4. In summary, the reported future ILI occurrence of 23985 (Week 22, 2022) can be explained by the steady upward trend in past ILI occurrences, the correlation between escalating weekly trends and future activity, the increasing outpatient ILI visit rates, rising hospitalizations, co-circulating respiratory viruses, and elevated PIC mortality. Combined, these factors provide a compelling basis for the intensified ILI activity observed after 5 weeks.